Clinical Evidence

Study 1

The effect of a serum containing acetyl hexapeptide-8, dipeptide diaminobutyroyl benzylamide diacetate and gluconolactone on skin biomarkers, wrinkles and skin texture: Ex vivo and clinical studies. Read more

Objective

This study aimed to explore the anti-skin aging efficacy of a novel serum through ex-vivo and clinical studies.

Results

Formula 1 significantly improved static and dynamic wrinkles and skin quality, with notable increases in collagen and elastic fibers.

Study 2

An Open-Label Study to Assess the Efficacy and Tolerability of a Multifunctional, 10-Peptide Face and Neck Serum to Address Skin Quality. Read more

Results

By Week 12, 89.6% of subjects showed clinical improvement in skin quality, indicating high satisfaction and tolerability.

Study 3

Establishment and application of perceived age prediction model for the periocular aging research of Chinese Han women. Read more

Conclusion

The study developed a model predicting perceived age, confirming the anti-aging efficacy of a cream containing peptides, including dipeptide diaminobutyroyl benzylamide diacetate.